In brief, what’s happening at Penn—whether it’s across campus or around the world.
The newly-digitized archive of Ed Ruscha's landmark series of Los Angeles photographs examines changes along Sunset Boulevard from 1966 to 2007.
FULL STORY AT Weitzman School of Design →
The Penn Transplant Institute’s new Center will expand care for living donors, helping to maximize the number of lives saved through liver and kidney transplantation.
FULL STORY AT Penn Medicine News →
The student-athletes, coaches, athletics administrators, alumni that comprise the Racial Justice Task Force has been divided into sub-committees to allow for more focused discussions and planning in specific areas of the Plan of Action: First Steps to Combat Racism. The task force will complete its full recommendations by the end of October.
FULL STORY AT Penn Athletics →
The Weitzman School has established the Julian Abele Fellowship in Architecture, which will be given annually to a graduate architecture student or students. The Fellowship is named for the first Black architect to graduate from Penn.
FULL STORY AT Weitzman School of Design →
FemmeHacks is Philadelphia’s first all-women collegiate hackathon, hosted by Penn’s Women in Computer Science chapter to empower, educate, and inspire women and nonbinary folks across the nation. This year’s event in February went virtual for the first time.
FULL STORY AT Mack Institute for Innovation Management →
Thanks to their top-14 performances at Saturday's Ivy League Heptagonal Cross Country Championships, Anthony Russo and Sam Webb were named second-team All-Ivy.
FULL STORY AT Penn Athletics →
At Penn Health-Tech’s Rothberg Catalyzer two-day makerthon that challenges interdisciplinary student teams to prototype and pitch medical devices, a team of Mechanical Engineering and Applied Mechanics graduate students won with their orthotic device that children with cerebral palsy can more comfortably wear as they sleep.
FULL STORY AT Penn Engineering Blog →
A team led by scientists in the Perelman School has identified nine potential new COVID-19 treatments, including three that are already approved by the Food and Drug Administration (FDA) for treating other diseases. The team screened thousands of existing drugs and drug-like molecules for their ability to inhibit the replication of the COVID-19-causing coronavirus, SARS-CoV-2.
FULL STORY AT Penn Medicine News →
